Document:

<Page>

                                                                   Exhibit 10.17

                           ART TECHNOLOGY GROUP, INC.

                              AGREEMENT AND RELEASE

Agreement made as of the 1st day of July, 2001 (the "Effective Date"), by and
between Art Technology Group, Inc., a Delaware corporation (the "Company")
having a principal place of business located at 25 First Street, Cambridge, MA
02141, and Ann C. Brady ("Brady"), an individual residing at 16 Church Street,
Westborough, Massachusetts 01581.

     Whereas Brady has been employed by the Company, most recently as its Vice
President, Finance and Chief Financial Officer, and

     Whereas, Brady has resigned that position and has agreed to become
Financial Advisor to the Company, both actions to be effective as of July 1,
2001;

     Whereas, Brady is party to a certain agreement, dated May 5, 1997, and
entitled "Invention. Non-Disclosure and Non-Solicitation Agreement" (the
"Proprietary Information Agreement); and

     Whereas, Brady's employment with the Company will terminate as of
December 31, 2002;

     Now, therefore, in consideration of the foregoing and the mutual covenants
contained herein, the parties agree as follows:

     1. TASKS. From July 1, 2001 through December 31, 2002 (the "Employment
Period"), Brady, in the capacity of Financial Advisor, shall perform the tasks
listed in Attachment 1.

     2. PAYMENTS. In consideration for her performance of the tasks identified
in Attachment 1, the Company will to pay to Brady as salary during the
Employment Period the total sum of $100,000 (One Hundred Thousand Dollars)
payable on a biweekly basis as follows: From July 1, 2001 through January 31,
2002, the Company shall pay to Brady the total sum of $60,000 (Sixty Thousand
Dollars); from February 1, 2002 through July 31, 2002, the Company shall pay to
Brady the total sum of $30,000 (Thirty Thousand Dollars); and from August 1
through December 31, 2002, the Company shall pay to Brady the total sum of
$10,000 (Ten Thousand Dollars). Such payment shall be subject to applicable
taxes, which shall remain the responsibility of the applicable party. Upon
reasonable notice, Brady shall be available five (5) days per month, on average,
to perform assignments from the Company.

     3. OTHER EMPLOYEE BENEFITS. Eligibility for health insurance, life
insurance, disability, and 401(k) participation will continue during the
Employment Period on the same terms and conditions as other Company employees.
Eligibility for all other benefits including without limitation bonus plan and
incentive plan shall cease as of July 1, 2001.

<PAGE>

     4. REIMBURSEMENT OF EXPENSES. The Company will reimburse Brady for expenses
reasonably incurred (in accordance with the Company's expense reimbursement
policy) in the performance of her duties within ten (10) business days of
receipt of documentation for said expenses.

     5. COMPANY PROPERTY. The Company acknowledges and agrees that Brady may
keep her Company-assigned personal computer, cellular telephone, and facsimile
machine for the duration of the Employment Period and shall return such company
property within 5 business days after the end of such period.

     6. STOCK OPTIONS. Brady's stock options shall continue to vest in
accordance with applicable vesting schedules, which are attached hereto as
Attachment 2. Vesting in Brady's stock options shall cease as of December 31,
2002. Brady shall not be eligible for any further stock option grants during the
Employment Period. In the event of a buyout, merger, or other change in
ownership during the 90-day period beginning on July 23, 2001, the Company shall
offer Brady vesting of her stock options on the same terms and conditions as
high level executives of the Company.

     7. OTHER EMPLOYMENT. Should Brady become a full-time employee of another
company, all salary, vesting, and benefits described in paragraphs 2 through 4
above shall immediately cease. Notwithstanding the foregoing, until December 31,
2002 Brady may perform consulting services not to exceed 32 hours per week
either individually or on behalf of another company, entity, or individual that
does not compete, directly or indirectly, with the Company.

     8. DIRECTORS AND OFFICERS INSURANCE. The Company agrees and acknowledges
that it will (a) continue to cover Brady under its Directors and Officers
Insurance coverage for work performed during the Employment Period and (b) fully
indemnify her for any and all liabilities related to duties performed on or
behalf of the Company.

     9. RELEASE OF ALL CLAIMS. Except as expressly otherwise provided in this
Agreement and except for any claims which arise because of breach of this
Agreement by the Company, Brady hereby waives, releases and promises never to
assert any and all claims that she has or might have against the Company and its
subsidiaries, officers, directors, stockholders, affiliates, agents, attorneys,
employees, successors or assigns, arising from or related to her employment with
Company, the termination of such employment or, as applicable, her status as an
officer or stockholder of the Company or any of its subsidiaries. The foregoing
release as it applies to officers, directors and other individuals is intended
to release such persons in all capacities, including individual and official.
The released claims include, but are not limited to, claims arising under
federal, state, and local statutory law, such as the Age Discrimination in
Employment Act, the Older Workers Benefit Protection Act, the Americans with
Disabilities Act, Title VII of the Civil Rights Act of 1964 and the laws of
contract and tort.

     10. NO DISPARAGEMENT. Neither Brady nor the Company will do anything for
the purpose of harming the business reputation, customer relations or employee

<PAGE>

or consultant relations of the other. Neither Brady nor the Company will make
any negative, disparaging or derogatory remarks about the other.

     11. GENERAL. This Agreement shall be governed by the laws of the
Commonwealth of Massachusetts, without regard to its choice of law provisions.
No amendment or waiver of this Agreement or any of its provisions shall be
binding upon the party against whom the enforcement of such amendment or waiver
is sought unless it is made in writing and signed by or on behalf of such party.
The waiver by either party of a breach of any provision of this Agreement by the
other party shall not operate as a waiver by that party of any subsequent breach
of the same or any other provision of this Agreement by the other party. This
Agreement shall be binding upon and inure to the benefit of the parties hereto
and their respective heirs, executors and administrators, successors and
assigns, except that it may not be assigned by Brady.

     This Agreement constitutes the final and entire agreement of the parties
with respect to the matters covered hereby and replaces and supersedes all other
agreements and understandings relating to any services that Brady has rendered
to the Company or any of its subsidiaries, except for the Proprietary
Information Agreement, and any rights and obligations pursuant to agreements
pertaining to stock options referred to in paragraph 4. Notwithstanding the
foregoing, the Company acknowledges and agrees that the at-will provision of the
Proprietary Information Agreement, Paragraph 6 thereto, is superseded by this
Agreement.

     This Agreement shall be interpreted so as to be effective and valid
under applicable law, but if any provision shall be deemed invalid, that
provision shall be ineffective to the extent that it is invalid, without
invalidating the remainder of such provision or any other provision of this
Agreement. If any one or more of the provisions contained in this Agreement
shall for any reason be held to be excessively broad as to duration,
geographical scope, activity or subject, such provisions shall be construed
by limiting and reducing it so as to be enforceable to the maximum extent
permitted by applicable law.

     12. COMPANY BLACKOUT PERIODS. Brady acknowledges and agrees that as an
employee in the Finance Department, she is subject to the restriction against
trading during the Company's official blackout periods. Brady expressly
agrees that she will not trade in the Company's stock at any time while in
possession of material inside information related to the Company.

     13. NOTICES. Notices are valid under this Agreement if in writing, signed
by the party providing the notice, and sent to the other party at the address
listed above by registered, certified mail, or express mail, or by courier.

<PAGE>

     IN WITNESS WHEREOF, this Agreement has been executed as a sealed instrument
as of the date first above written.

                              Art Technology Group, Inc.

/s/ Ann Brady
---------------------------   By: /s/ Jeet Singh
                              -------------------------------
    Ann Brady                  Jeet Singh
                               Chief Executive Officer

<PAGE>

                                                            Attachment 1

Definition of Duties:

o Transfer of knowledge: ATG financial history, specifics of investor
  relations, culture, finance organization and staff
o Advisor/mentor of staff
o Financial planning and modeling
o Assist in budgeting, forecasting, development and implementation of ongoing
  strategic financial planEXHIBIT 4.6

THIS WARRANT AND THE UNDERLYING
SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED (THE “ACT”).  THEY MAY NOT BE
SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE
REGISTRATION STATEMENT AS TO SUCH SECURITIES UNDER THE ACT OR AN OPINION OF
COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.

OMNICELL, INC.

WARRANT TO PURCHASE COMMON STOCK

	
  No. CW-1

  	
   

  	
  October 31, 2001

  

Void
After  October 31, 2006

THIS CERTIFIES THAT, for value received, ASCENSION HEALTH VENTURES, LLC with its principal
office at 4600 Edmundson Road, St. Louis, MO 
63134 or assigns (the “Holder”), is entitled to subscribe for and
purchase at the Exercise Price (defined below) from OMNICELL, INC.,
a Delaware corporation, with its principal office at 1101 East Meadow Drive,
Palo Alto, CA  94303 (the “Company”) up
to One
Hundred Seventy-Three Thousand Four Hundred Ten (173,410) shares of
Common Stock of the Company (the “Stock”).

 

 

1.             DEFINITIONS. 
As
used herein, the following terms shall have the following respective meanings:

(a)           “Exercise Period” shall mean the period
commencing with the date hereof and ending 5 years from the date hereof, unless
sooner terminated as provided below.

(b)           “Exercise Price” shall mean $8.745 per
share, subject to adjustment pursuant to Section 5 below.

(c)           “Exercise Shares” shall mean the shares
of the Company’s Stock issuable upon exercise of this Warrant.

2.             EXERCISE
OF WARRANT.  The rights represented by this Warrant
are not subject to vesting and may be exercised in whole or in part at any time
during the Exercise Period, by delivery of the following to the Company at its
address set forth above (or at such other address as it may designate by notice
in writing to the Holder):

(a)           An executed Notice of Exercise in the
form attached hereto;

(b)           Payment of the Exercise Price either (i)
in cash or by check, or (ii) by cancellation of indebtedness; and

(c)           This Warrant.

Upon the exercise of the
rights represented by this Warrant, a certificate or certificates for the
Exercise Shares so purchased, registered in the name of the Holder or persons
affiliated with the Holder, if the Holder so designates, shall be issued and
delivered to the Holder within a reasonable time after the rights represented
by this Warrant shall have been so exercised.

1

 

The person in whose name
any certificate or certificates for Exercise Shares are to be issued upon
exercise of this Warrant shall be deemed to have become the holder of record of
such shares on the date on which this Warrant was surrendered and payment of
the Exercise Price was made, irrespective of the date of delivery of such
certificate or certificates, except that, if the date of such surrender and
payment is a date when the stock transfer books of the Company are closed, such
person shall be deemed to have become the holder of such shares at the close of
business on the next succeeding date on which the stock transfer books are
open.

2.1          Net
Exercise.  Notwithstanding any provisions herein to the
contrary, if the fair market value of one share of the Company’s Common Stock
is greater than the Exercise Price (at the date of calculation as set forth
below), in lieu of exercising this Warrant by payment of cash, the Holder may
elect to receive shares equal to the value (as determined below) of this
Warrant (or the portion thereof being canceled) by surrender of this Warrant at
the principal office of the Company together with the properly endorsed Notice
of Exercise in which event the Company shall issue to the Holder a number of
shares of Stock computed using the following formula:

X = Y (A-B)

A

Where    X =          the
number of shares of Stock to be issued to the Holder

Y =                              the number of shares of Stock purchasable
under the Warrant or, if only a portion of the Warrant is being exercised, the
portion of the Warrant being canceled (at the date of such calculation)

A =                            the fair market value of one share of the
Company’s Common Stock (at the date of such calculation)

B =                              Exercise Price (as adjusted to the date
of such calculation)

For purposes of the above
calculation, the fair market value of one share of Common Stock shall be:

(a)            the average daily Market Price (as
defined below) during the period of the most recent 10 business days, ending on
the last business day before the effective date of exercise, on which the
national securities exchanges were open for trading; or

(b)           if no class of Common Stock is then
listed or admitted to trading on any national securities exchange or quoted in
the over-counter market, the fair market value shall be the Market Price on the
last business day before the effective date of exercise.

If the Stock is traded on
a national securities exchange or admitted to unlisted trading privileges on
such an exchange, or is listed on the National Market System (the “National
Market System”) of the Nasdaq, the Market Price as of a specified day shall be
the last reported sale price of Common Stock on such exchange or on the
National Market System on such date or if no such sale is made on such day, the
mean of the closing bid and asked prices for such day on such exchange or on
the National Market System.  If the
Common Stock is not so listed or admitted to unlisted trading privileges, the
Market Price as of a specified day shall be the mean of the last bid and asked
prices reported on such date (x) by the Nasdaq or (y) if reports are
unavailable under clause (x) above by the National Quotation Bureau
Incorporated.  If the Common Stock is
not so listed or admitted to unlisted trading privileges and bid and 

2

 

ask prices are not
reported, the Market Price as of a specified day shall be determined in good
faith by the Board of Directors of the Company.

3.             COVENANTS
OF THE COMPANY.

3.1          Covenants
as to Exercise Shares.  The Company covenants and
agrees that all Exercise Shares that may be issued upon the exercise of the
rights represented by this Warrant will, upon issuance, be validly issued and
outstanding, fully paid and nonassessable, and free from all taxes, liens and
charges with respect to the issuance thereof. 
The Company further covenants and agrees that the Company will at all
times during the Exercise Period, have authorized and reserved, free from
preemptive rights, a sufficient number of shares of its Common Stock to provide
for the exercise of the rights represented by this Warrant.  If at any time during the Exercise Period
the number of authorized but unissued shares of Stock shall not be sufficient
to permit exercise of this Warrant, the Company will take such corporate action
as may, in the opinion of its counsel, be necessary to increase its authorized
but unissued shares of Stock to such number of shares as shall be sufficient for
such purposes.

3.2          No
Impairment.  Except and to the extent as waived or
consented to by the Holder, the Company will not, by amendment of its
Certificate of Incorporation or through any reorganization, transfer of assets,
consolidation, merger, dissolution, issue or sale of securities or any other
voluntary action, avoid or seek to avoid the observance or performance of any
of the terms to be observed or performed hereunder by the Company, but will at
all times in good faith assist in the carrying out of all the provisions of
this Warrant and in the taking of all such action as may be necessary or
appropriate in order to protect the exercise rights of the Holder against
impairment.

3.3          Notices
of Record Date.  In the event of any taking by the Company of
a record of the holders of any class of securities for the purpose of
determining the holders thereof who are entitled to receive any dividend (other
than a cash dividend which is the same as cash dividends paid in previous
quarters) or other distribution, the Company shall mail to the Holder, at least
ten (10) days prior to the date specified herein, a notice specifying the date
on which any such record is to be taken for the purpose of such dividend or
distribution.

4.             REPRESENTATIONS
OF HOLDER.

4.1          Acquisition
of Warrant for Personal Account.  The Holder
represents and warrants that it is acquiring the Warrant solely for its account
for investment and not with a view to or for sale or distribution of said
Warrant or any part thereof.  The Holder
also represents that the entire legal and beneficial interests of the Warrant
and Exercise Shares the Holder is acquiring is being acquired for, and will be
held for, its account only.

4.2          Securities
Are Not Registered.

(a)           The Holder understands that the Warrant
and the Exercise Shares have not been registered under the Securities Act of
1933, as amended (the “Act”).  The
Holder realizes that the basis for the exemption from registration may not be
present if, notwithstanding its representations, the Holder has a present
intention of acquiring the securities for a fixed or determinable period in the
future, selling (in connection with a distribution or otherwise), granting any
participation in, or otherwise distributing the securities.  The Holder has no such present intention.

(b)           The Holder recognizes that the Warrant
and the Exercise Shares must be held indefinitely unless they are subsequently
registered under the Act or an exemption from such registration

3

 

is available.  The Holder recognizes that the Company has
no obligation to register the Warrant or the Exercise Shares of the Company, or
to comply with any exemption from such registration.

(c)           The Holder is aware that neither the
Warrant nor the Exercise Shares may be sold pursuant to Rule 144 adopted under
the Act unless certain conditions are met, including, among other things, the
existence of a public market for the shares, the availability of certain
current public information about the Company, the resale following the required
holding period under Rule 144 and the number of shares being sold during any
three month period not exceeding specified limitations.  Holder is aware that the conditions for
resale set forth in Rule 144 have not been satisfied and that the Company
presently has no plans to satisfy these conditions in the foreseeable future.

4.3          Disposition
of Warrant and Exercise Shares.

(a)           The Holder further agrees not to make any
disposition of all or any part of the Warrant or Exercise Shares in any event
unless and until:

(i)            The Company shall have received a letter secured by
the Holder from the Securities and Exchange Commission stating that no action
will be recommended to the Commission with respect to the proposed disposition;
or

(ii)           There is then in effect a registration statement under
the Act covering such proposed disposition and such disposition is made in
accordance with said registration statement; or

(iii)         The Holder shall have notified the Company of the
proposed disposition and shall have furnished the Company with a detailed
statement of the circumstances surrounding the proposed disposition, and if
reasonably requested by the Company, the Holder shall have furnished the
Company with an opinion of counsel, reasonably satisfactory to the Company, for
the Holder to the effect that such disposition will not require registration of
such Warrant or Exercise Shares under the Act or any applicable state
securities laws.

(b)           The Holder understands and agrees that
all certificates evidencing the shares to be issued to the Holder may bear the
following legends:

THESE SECURITIES
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
“ACT”).  THEY MAY NOT BE SOLD, OFFERED
FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION
STATEMENT AS TO THE SECURITIES UNDER THE ACT OR AN OPINION OF COUNSEL
SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.

THE SHARES
REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO AN AGREEMENT BY THE REGISTERED
HOLDER HEREOF NOT TO SELL SUCH SHARES (“THE LOCK-UP AGREEMENT”) FOR A PERIOD OF
180 DAYS AFTER THE DATE OF THE FINAL PROSPECTUS FOR THE PUBLIC OFFERING. SUCH
LOCK-UP AGREEMENT EXPIRES BY ITS TERMS ON FEBRUARY 3, 2002, 180 DAYS FOLLOWING
THE DATE OF THE FINAL PROSPECTUS.

 

5.             ADJUSTMENT OF EXERCISE PRICE.  In the event of changes in the outstanding Stock of
the Company by reason of stock dividends, split-ups, recapitalizations,
reclassifications, combinations or exchanges of shares, separations,
reorganizations, liquidations, or the like, the number and class of shares
available under the Warrant in the aggregate and the Exercise Price shall be
correspondingly adjusted to

4

 

give the Holder of the
Warrant, on exercise for the same aggregate Exercise Price, the total number,
class, and kind of shares as the Holder would have owned had the Warrant been
exercised prior to the event and had the Holder continued to hold such shares
until after the event requiring adjustment; provided, however, that such
adjustment shall not be made with respect to, and this Warrant shall terminate
if not exercised prior to, the events set forth in Section 7 below.  The form of this Warrant need not be changed
because of any adjustment in the number of Exercise Shares subject to this
Warrant.

6.             FRACTIONAL SHARES.  No fractional shares shall be issued upon the exercise of this Warrant
as a consequence of any adjustment pursuant hereto.  All Exercise Shares (including fractions) issuable upon exercise
of this Warrant may be aggregated for purposes of determining whether the
exercise would result in the issuance of any fractional share.  If, after aggregation, the exercise would
result in the issuance of a fractional share, the Company shall, in lieu of
issuance of any fractional share, pay the Holder otherwise entitled to such
fraction a sum in cash equal to the product resulting from multiplying the then
current fair market value of an Exercise Share by such fraction.

7.             EARLY TERMINATION.  In the event of, at any time during the Exercise Period, any capital
reorganization, or any reclassification of the capital stock of the Company
(other than a change in par value or from par value to no par value or no par
value to par value or as a result of a stock dividend or subdivision, split-up
or combination of shares), or the consolidation or merger of the Company with
or into another corporation (other than a merger solely to effect a
reincorporation of the Company into another state), or the sale or other
disposition of all or substantially all the properties and assets of the
Company in its entirety to any other person, the Company shall provide to the
Holder twenty (20) days advance written notice of such reorganization,
reclassification, consolidation, merger or sale or other disposition of the
Company’s assets, and this Warrant shall terminate unless exercised prior to
the date such public offering is closed or the occurrence of such
reorganization, reclassification, consolidation, merger or sale or other
disposition of the Company’s assets.

8.     MARKET
STAND-OFF AGREEMENT.  Holder shall not sell, dispose of,
transfer, make any short sale of, grant any option for the purchase of, or
enter into any hedging or similar transaction with the same economic effect as
a sale, any Common Stock (or other securities) of the Company held by Holder,
for a period of one hundred eighty (180 days) following the effective date of
the registration statement of the Company filed under the Securities Act of
1933. Holder agrees to execute and deliver such other agreements as may be
reasonably requested by the Company and/or the managing underwriter(s) which
are consistent with the foregoing or which are necessary to give further effect
thereto.  In order to enforce the foregoing
covenant, the Company may impose stop-transfer instructions with respect to
such Common Stock (or other securities) until the end of such period.  The underwriters of the Company’s stock are
intended third party beneficiaries of this Section 8 and shall have the right,
power and authority to enforce the provisions hereof as though they were a
party hereto.

9.             NO STOCKHOLDER RIGHTS.  This Warrant in and of itself shall not entitle the
Holder to any voting rights or other rights as a stockholder of the Company.

10.          TRANSFER OF WARRANT.  Subject to applicable laws and the restriction on transfer set forth on
the first page of this Warrant, this Warrant and all rights hereunder are
transferable, by the Holder in person or by duly authorized attorney, upon
delivery of this Warrant and the form of assignment attached hereto to any
transferee designated by Holder.  The
transferee shall sign an investment letter in form and substance satisfactory
to the Company.

11.          LOST, STOLEN, MUTILATED OR DESTROYED WARRANT.  If this Warrant is lost, stolen, mutilated or
destroyed, the Company may, on such terms as to indemnity or otherwise as it
may reasonably impose (which shall, in the case of a mutilated Warrant, include
the surrender thereof), issue a

5

 

new Warrant of like
denomination and tenor as the Warrant so lost, stolen, mutilated or
destroyed.  Any such new Warrant shall
constitute an original contractual obligation of the Company, whether or not
the allegedly lost, stolen, mutilated or destroyed Warrant shall be at any time
enforceable by anyone.

12.          NOTICES, ETC. 
All
notices required or permitted hereunder shall be in writing and shall be deemed
effectively given: (a) upon personal delivery to the party to be notified,
(b) when sent by confirmed telex or facsimile if sent during normal
business hours of the recipient, if not, then on the next business day,
(c) five (5) days after having been sent by registered or certified mail,
return receipt requested, postage prepaid, or (d) one (1) day after
deposit with a nationally recognized overnight courier, specifying next day
delivery, with written verification of receipt.  All communications shall be sent to the Company at the address
above and to Holder at 4600 Edmundson Road, St. Louis, MO  63134 or at such other address as the
Company or Holder may designate by ten (10) days advance written notice to the
other parties hereto.

13.          ACCEPTANCE. 
Receipt
of this Warrant by the Holder shall constitute acceptance of and agreement to
all of the terms and conditions contained herein.

14.          GOVERNING LAW.  This Warrant and all rights, obligations and liabilities hereunder
shall be governed by the laws of the State of California.

6

 

IN WITNESS
WHEREOF, the
Company has caused this Warrant to be executed by its duly authorized officer
as of October 31, 2001.

OMNICELL, INC.

	
   

  	
  By:

  	
  /s/ Sheldon
  D.Asher

  
	
   

  	
   

  	
   

  
	
   

  	
  Name:

  	
  Sheldon D. Asher

  
	
   

  	
   

  	
   

  
	
   

  	
  Title:

  	
  President & CEO

  
	
   

  	
   

  	
   

  
	
   

  	
  Address:

  	
  Palo Alto, CA

  
					

 

7

NOTICE
OF EXERCISE

TO: 
OMNICELL, INC.

(1)           o            The
undersigned hereby elects to purchase ________ shares of the Common Stock of Omnicell,
Inc. (the “Company”) pursuant to the terms of the attached Warrant,
and tenders herewith payment of the exercise price in full, together with all
applicable transfer taxes, if any.

                o            The
undersigned hereby elects to purchase ________ shares of the Common Stock of Omnicell,
Inc. (the “Company”) pursuant to the terms of the net exercise
provisions set forth in Section 2.1 of the attached Warrant, and shall
tender payment of all applicable transfer taxes, if any.

(2)           Please issue a
certificate or certificates representing said shares of Common Stock in the
name of the undersigned or in such other name as is specified below:

________________________

(Name)

________________________

________________________

(Address)

(3)           The undersigned
represents that (i) the aforesaid shares of Common Stock are being acquired for
the account of the undersigned for investment and not with a view to, or for
resale in connection with, the distribution thereof and that the undersigned
has no present intention of distributing or reselling such shares; (ii) the
undersigned is aware of the Company’s business affairs and financial condition
and has acquired sufficient information about the Company to reach an informed
and knowledgeable decision regarding its investment in the Company; (iii) the
undersigned is experienced in making investments of this type and has such
knowledge and background in financial and business matters that the undersigned
is capable of evaluating the merits and risks of this investment and protecting
the undersigned’s own interests; (iv) the undersigned understands that the shares
of Common Stock issuable upon exercise of this Warrant have not been registered
under the Securities Act of 1933, as amended (the “Securities Act”), by reason
of a specific exemption from the registration provisions of the Securities Act,
which exemption depends upon, among other things, the bona fide nature of the
investment intent as expressed herein, and, because such securities have not
been registered under the Securities Act, they must be held indefinitely unless
subsequently registered under the Securities Act or an exemption from such
registration is available; (v) the undersigned is aware that the aforesaid
shares of Common Stock may not be sold pursuant to Rule 144 adopted under the
Securities Act unless certain conditions are met and until the undersigned has
held the shares for the number of years prescribed by Rule 144, that among the
conditions for use of the Rule is the availability of current information to
the public about the Company and the Company has not made such information
available and has no present plans to do so; and (vi) the undersigned agrees
not to make any disposition of all or any part of the aforesaid shares of
Common Stock unless and until there is then in effect a registration statement
under the Securities Act covering such proposed disposition and such
disposition is made in accordance with said registration statement, or the
undersigned has provided the Company with an opinion of counsel satisfactory to
the Company, stating that such registration is not required.

	
   

  	
   

  	
   

  
	
  (Date)

  	
   

  	
  (Signature)

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  (Print name)

  

 

 

 

ASSIGNMENT FORM

(To assign the
foregoing Warrant, execute this form and supply required information.  Do not use this form to purchase shares.)

FOR VALUE RECEIVED, the foregoing Warrant and all rights
evidenced thereby are hereby assigned to

	
  Name:

  	
   

  
	
  (Please Print)

  
	
   

  	
   

  
	
  Address:

  	
   

  
	
  (Please Print)

  
	
   

  	
   

  

 

Dated: 
__________, 20__

	
  Holder’s

  	
   

  
	
  Signature:

  	
   

  
	
   

  	
   

  
	
  Holder’s

  	
   

  
	
  Address:

  	
   

  

 

 

 

NOTE:  The signature to this
Assignment Form must correspond with the name as it appears on the face of the
Warrant, without alteration or enlargement or any change whatever.  Officers of corporations and those acting in
a fiduciary or other representative capacity should file proper evidence of
authority to assign the foregoing Warrant.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00035-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00035-of-00352.parquet"}]]